Corporate Member Spotlight: Xoltar
- 13 minutes ago
- 1 min read
XOLTAR is building the only lifelong AI companion for behavior change and emotional support which is pharma-grade safe. The company’s platform combines conversational AI with evidence-based behavioral protocols to support patients through challenging health journeys such as cancer, weight management, smoking cessation, and a variety of chronic conditions.
By delivering personalized guidance, emotional support, and continuous engagement through mobile experiences, XOLTAR helps patients stay adherent to treatment, improve outcomes, and reduce the burden on care teams. XOLTAR works with pharmaceutical companies, hospitals, and payers to scale high-touch patient support using safe, structured AI companions.
Comments